Literature DB >> 2834017

Quantitative changes in hippocampal structure following long-term exposure to delta 9-tetrahydrocannabinol: possible mediation by glucocorticoid systems.

P W Landfield1, L B Cadwallader, S Vinsant.   

Abstract

Although cannabinoids exert strong effects on brain function, there have been no extensive analyses of the long-term effects of cannabinoids on mammalian brain structure. Consequently, we conducted quantitative light and electron microscopic studies on the brains of rats treated chronically with delta 9-tetrahydrocannabinol (THC) (5 X weekly for 8 months--approximately 30% of the life-span). In these studies, we found significant THC-induced changes in hippocampal structure: specifically, THC-treated animals exhibited decreased neuronal density and increased glial cell reactivity (i.e. an increase of cytoplasmic inclusions). In addition, we confirmed prior reports of THC-induced increases in adrenal-pituitary activity, since both adrenocorticotropic hormone (ACTH) and corticosterone were elevated substantially during an acute stress. However, the animals appeared to be only minimally affected behaviorally by the doses used (highest dose: 8 mg/kg) and no effects of THC were observed on several ultrastructural variables, including synaptic density. The observed hippocampal morphometric effects of chronic THC are similar to apparent glucocorticoid-dependent changes that previously have been found to develop in rat hippocampus during normal aging. Given that cannabinoids and steroids are similar in chemical structure in several respects, therefore, the present results seem to raise the possibility that chronic THC exposure may alter hippocampal anatomical structure by interactions with, or mimicry of, adrenal steroid activity.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2834017     DOI: 10.1016/0006-8993(88)91597-1

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  36 in total

1.  Associations between cannabinoid receptor-1 (CNR1) variation and hippocampus and amygdala volumes in heavy cannabis users.

Authors:  Joseph P Schacht; Kent E Hutchison; Francesca M Filbey
Journal:  Neuropsychopharmacology       Date:  2012-06-06       Impact factor: 7.853

2.  Altered parahippocampal functioning in cannabis users is related to the frequency of use.

Authors:  Benjamin Becker; Daniel Wagner; Euphrosyne Gouzoulis-Mayfrank; Elmar Spuentrup; Jörg Daumann
Journal:  Psychopharmacology (Berl)       Date:  2010-03-19       Impact factor: 4.530

3.  Effects of alcohol and combined marijuana and alcohol use during adolescence on hippocampal volume and asymmetry.

Authors:  Krista Lisdahl Medina; Alecia D Schweinsburg; Mairav Cohen-Zion; Bonnie J Nagel; Susan F Tapert
Journal:  Neurotoxicol Teratol       Date:  2006-12-12       Impact factor: 3.763

4.  Neuropsychological functioning in adolescent marijuana users: subtle deficits detectable after a month of abstinence.

Authors:  Krista Lisdahl Medina; Karen L Hanson; Alecia D Schweinsburg; Mairav Cohen-Zion; Bonnie J Nagel; Susan F Tapert
Journal:  J Int Neuropsychol Soc       Date:  2007-09       Impact factor: 2.892

Review 5.  Neurochemistry of drug action: insights from proton magnetic resonance spectroscopic imaging and their relevance to addiction.

Authors:  Stephanie C Licata; Perry F Renshaw
Journal:  Ann N Y Acad Sci       Date:  2010-02       Impact factor: 5.691

6.  Long-term behavioral and biochemical effects of an ultra-low dose of Δ9-tetrahydrocannabinol (THC): neuroprotection and ERK signaling.

Authors:  Miriam Fishbein; Sahar Gov; Fadi Assaf; Mikhal Gafni; Ora Keren; Yosef Sarne
Journal:  Exp Brain Res       Date:  2012-07-22       Impact factor: 1.972

Review 7.  Neuropathology of substance use disorders.

Authors:  Jean Lud Cadet; Veronica Bisagno; Christopher Mark Milroy
Journal:  Acta Neuropathol       Date:  2013-11-29       Impact factor: 17.088

8.  Role of the endogenous cannabinoid system as a modulator of dopamine transmission: implications for Parkinson's disease and schizophrenia.

Authors:  F Rodríguez De Fonseca; M A Gorriti; A Bilbao; L Escuredo; L M García-Segura; D Piomelli; M Navarro
Journal:  Neurotox Res       Date:  2001-01       Impact factor: 3.911

9.  Δ(9)Tetrahydrocannabinol impairs reversal learning but not extra-dimensional shifts in rhesus macaques.

Authors:  M J Wright; S A Vandewater; L H Parsons; M A Taffe
Journal:  Neuroscience       Date:  2013-01-16       Impact factor: 3.590

10.  Lifetime use of cannabis from longitudinal assessments, cannabinoid receptor (CNR1) variation, and reduced volume of the right anterior cingulate.

Authors:  Shirley Y Hill; Vinod Sharma; Bobby L Jones
Journal:  Psychiatry Res Neuroimaging       Date:  2016-07-19       Impact factor: 2.376

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.